CYP46A1 T/C polymorphism associated with the APOEε4 allele increases the risk of Alzheimer's disease

Journal of Neurology

Volumn 260, Issue 7, 2013, Pages 1701-1708

  Li, Ling ^a   Yin, Zegang ^a   Liu, Juan ^a   Li, Gongbo ^a   Wang, Yanjiang ^a   Yan, Jiachuan ^a   Zhou, Huadong ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease (AD); Apolipoprotein E (APOE); Cholesterol 24S hydroxylase gene (CYP46A1); Meta analysis; Polymorphism

Indexed keywords

APOLIPOPROTEIN E4; CHOLESTEROL 24S HYDROXYLASE; OXYGENASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; CASE CONTROL STUDY; CONTROLLED STUDY; DSM-III-R; DSM-IV; ENVIRONMENTAL FACTOR; ETHNICITY; GENETIC ASSOCIATION; GENETIC RISK; GENETICS; GENOTYPING TECHNIQUE; HUMAN; INFORMATION RETRIEVAL; INTRON; MAJOR CLINICAL STUDY; NEUROIMAGING; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; STEROID HYDROXYLASES;

EID: 84880272606     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6690-4     Document Type: Review

References (44)

1. St George-Hyslop PH (2000) Genetic factors in the genesis of Alzheimer's disease. Ann NY Acad Sci 924:1-7
2. Bertram L (2009) Alzheimer's disease genetics current status and future perspectives. Int Rev Neurobiol 84:167-184
3. Lambert JC, Amouyel P (2011) Genetics of Alzheimer's disease: new evidences for an old hypothesis? Curr Opin Genet Dev 21:295-301 (Epub 1 Mar 2011)
4. Lambert JC, Heath S, Even G et al (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41:1094-1099 (Epub 6 Sept 2009)
5. Sleegers K, Lambert JC, Bertram L et al (2010) The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects. Trends Genet 26:84-93 (Epub 18 Jan 2010)
6. Seshadri S, Fitzpatrick AL, Ikram MA et al (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303:1832-1840
7. Martins IJ, Berger T, Sharman MJ et al (2009) Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease. J Neurochem 111:1275-1308
8. D'Errico G, Vitiello G, Ortona O et al (2008) Interaction between Alzheimer's Abeta (25-35) peptide and phospholipid bilayers: the role of cholesterol. Biochim Biophys Acta 1778:2710-2716 (Epub 28 Jul 2008)
9. Vitiello G, Grimaldi M, Ramunno A et al (2010) Interaction of a beta-sheet breaker peptide with lipid membranes. J Pept Sci 16:115-122
10. Bjorkhem I, Lutjohann D, Diczfalusy U et al (1998) Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res 39:1594-1600
11. Papassotiropoulos A, Streffer JR, Tsolaki M et al (2003) Increased brain β-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch Neurol 60:29-35
12. Borroni B, Archetti S, Agosti C et al (2004) Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer disease: from risk factors to disease modulators. Neurobiol Aging 25:747-751
13. Tedde A, Rotondi M, Cellini E et al (2006) Lack of association between the CYP46 gene polymorphism and Italian late-onset sporadic Alzheimer's disease. Neurobiol Aging 27:773.e1-773.e3 (Epub 1 Aug 2005)
14. Alzheimer research forum (2009) (updated 29 Jan 2010) Gene overview of all published AD-association studies for CYP46A1. Available at http://www.alzgene.org/geneoverview.asp?geneID=105
15. Bertram L, McQueen MB, Mullin K et al (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 39:17-23
16. Fu BY, Ma SL, Tang NL et al (2009) Cholesterol 24-hydroxylase (CYP46A1) polymorphisms are associated with faster cognitive deterioration in Chinese older persons: a two-year follow up study. Int J Geriatr Psychiatry 24:921-926
17. He XM, Zhang ZX, Zhang JW et al (2006) An intronic cholesterol 24S-hydroxylase polymorphism associated with Alzheimer disease. Chin J Neurol 39:44-47
18. Wang F, Jia JP (2007) Correlation of cholesterol 24-hydroxylase and ATP-binding cassette transporter A1 polymorphisms with Alzheimer's disease. Zhonghua Yi Xue Za Zhi 87:614-618
19. Li Y, Chu LW, Wang B et al (2010) CYP46A1 functional promoter haplotypes decipher genetic susceptibility to Alzheimer's disease. J Alzheimers Dis 21:1311-1323
20. Kölsch H, Lütjohann D, Jessen F et al (2009) CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism. Eur Psychiatry 24:183-190 (Epub 16 Mar 2009)
21. Vega GL, Weiner MF (2007) Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: effects of gender, CYP46, and ApoE polymorphisms. J Mol Neurosci 33:51-55
22. Shibata N, Kawarai T, Lee JH et al (2006) Association studies of cholesterol metabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer's disease. Neurosci Lett 391:142-146 (Epub 12 Sep 2005)
23. Helisalmi S, Vepsäläinen S, Koivisto AM et al (2006) Association of CYP46 intron 2 polymorphism in Finnish Alzheimer's disease samples and a global scale summary. J Neurol Neurosurg Psychiatry 77:421-422
24. Desai P, DeKosky ST, Kamboh MI (2002) Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease. Neurosci Lett 328:9-12
25. Kölsch H, Lütjohann D, Ludwig M (2002) Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease. Mol Psychiatry 7:899-902
26. Chalmers KA, Culpan D, Kehoe PG et al (2004) APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease. Neuroreport 15:95-98
27. Combarros O, Infante J, Llorca J, Berciano J (2004) Genetic association of CYP46 and risk for Alzheimer's disease. Dement Geriatr Cogn Disord 18:257-260 (Epub 29 Jul 2004)
28. Ingelsson M, Jesneck J, Irizarry MC, Hyman BT, Rebeck GW (2004) Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease. Neurosci Lett 367:228-231
29. Johansson A, Katzov H, Zetterberg H et al (2004) Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer's disease. Hum Genet 114:581-587 (Epub 18 Mar 2004)
30. Kabbara A, Payet N, Cottel D (2004) Exclusion of CYP46 and APOM as candidate genes for Alzheimer's disease in a French population. Neurosci Lett 363:139-143
31. Wang B, Zhang C, Zheng W et al (2004) Association between a T/C polymorphism in intron 2 of cholesterol 24S-hydroxylase gene and Alzheimer's disease in Chinese. Neurosci Lett 369:104-107
32. Golanska E, Hulas-Bigoszewska K, Wojcik I et al (2005) CYP46: a risk factor for Alzheimer's disease or a coincidence? Neurosci Lett 383:105-108 (Epub 21 Apr 2005)
33. Juhász A, Rimanóczy A, Boda K et al (2005) CYP46 T/C polymorphism is not associated with Alzheimer's dementia in a population from Hungary. Neurochem Res 30:943-948
34. Fernández Del Pozo V, Alvarez Alvarez M, Fernández Martínez M et al (2005) Polymorphism in the cholesterol 24S-hydroxylase gene (CYP46A1) associated with the APOEpsilon3 allele increases the risk of Alzheimer's disease and of mild cognitive impairment progressing to Alzheimer's disease. Dement Geriatr Cogn Disord 21:81-87 (Epub 9 Dec 2005)
35. Li Y, Chu LW, Chen YQ et al (2006) Intron 2 (T/C) CYP46 polymorphism is associated with Alzheimer's disease in Chinese patients. Dement Geriatr Cogn Disord 22:399-404 (Epub 8 Sept 2006)
36. Ma SL, Tang NL, Lam LC, Chiu HF (2006) Polymorphisms of the cholesterol 24-hydroxylase (CYP46A1) gene and the risk of Alzheimer's disease in a Chinese population. Int Psychogeriatr 18:37-45
37. Wang F, Jia J (2007) Polymorphisms of cholesterol metabolism genes CYP46 and ABCA1 and the risk of sporadic Alzheimer's disease in Chinese. Brain Res 1147:34-38 (Epub 8 Feb 2007)
38. Golanska E, Hulas-Bigoszewska K, Sieruta M et al (2009) Earlier onset of Alzheimer's disease: risk polymorphisms within PRNP, PRND, CYP46, and APOE genes. J Alzheimers Dis 17:359-368
39. Ghebranious N, Mukesh B, Giampietro PF et al (2011) A pilot study of gene/gene and gene/environment interactions in Alzheimer disease. Clin Med Res 9:17-25 (Epub 3 Aug 2010)
40. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3:186-191
41. Olgiati P, Politis AM, Papadimitriou GN, De Ronchi D, Serretti A (2011) Genetics of late-onset Alzheimer's disease: update from the alzgene database and analysis of shared pathways. Int J Alzheimers Dis 832379 (Epub 10 Dec 2011)
42. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K (2005) Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64:277-281
43. Llorca J, Rodríguez-Rodríguez E, Dierssen-Sotos T et al (2008) Meta-analysis of genetic variability in the beta-amyloid production, aggregation and degradation metabolic pathways and the risk of Alzheimer's disease. Acta Neurol Scand 117:1-14 (Epub 14 Sept 2007)
44. Dietschy JM, Turley SD (2001) Cholesterol metabolism in the brain. Curr Opin Lipidol 12:105-112